Department of Pediatrics, Gastroenterology, Hepatology, Nutrition, Allergology and Pulmonology, Medical University of Białystok, Białystok, Poland.
Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, Poland.
Med Sci Monit. 2023 Sep 2;29:e941195. doi: 10.12659/MSM.941195.
BACKGROUND In recent years, an increasing prevalence of Helicobacter pylori resistance to antibiotics has been observed. The aim of this study was to assess antibiotic resistance of Helicobacter pylori in previously untreated children from northeast Poland. MATERIAL AND METHODS Inclusion criteria comprised suspicion of Helicobacter pylori infection based on the presence of Helicobacter pylori antigen in the stool and/or characteristic macroscopic lesions seen on esophagogastroduodenoscopy. Samples of the gastric and/or duodenal mucosa were collected from 82 children with a median age of 13 years (range 3-17) during esophagogastroduodenoscopy between February 2019 and May 2022. The material was cultured, and positive Helicobacter pylori strains were tested for drug resistance to amoxicillin, metronidazole, and clarithromycin using the quantitative antibiotic concentration gradient stripe method E-test. RESULTS Based on biopsy culture, Helicobacter pylori infection was confirmed in 50 (61%) children. Helicobacter pylori resistance was most common to clarithromycin (n=19; 38%), followed by metronidazole (n=15; 30%), and the least frequent to amoxicillin (n=13; 26%). The resistance to 1 antibiotic was found in 14 children (28%). Double-drug resistance was noted in 3 children (6%) and triple drug resistance in 9 children (18%). In the whole group, 24 children (48%) were susceptible to all 3 antibiotics. CONCLUSIONS In this study, conducted for the first time in treatment-naïve children in northeast Poland, we found a high proportion of Helicobacter pylori strains resistant to at least 1 antibiotic. Our results may help in the appropriate choice of antibiotics for treatment of Helicobacter pylori in our region.
近年来,幽门螺杆菌对抗生素的耐药性呈上升趋势。本研究旨在评估波兰东北部未经治疗的儿童中幽门螺杆菌的抗生素耐药性。
纳入标准包括基于粪便中存在幽门螺杆菌抗原和/或食管胃十二指肠镜检查中观察到的特征性宏观病变,怀疑存在幽门螺杆菌感染。2019 年 2 月至 2022 年 5 月期间,在食管胃十二指肠镜检查中,从 82 名中位年龄为 13 岁(范围 3-17 岁)的儿童中采集胃和/或十二指肠黏膜样本。对这些样本进行培养,采用定量抗生素浓度梯度条带法 E 试验对阳性幽门螺杆菌菌株进行阿莫西林、甲硝唑和克拉霉素耐药性检测。
根据活检培养,50 名(61%)儿童确认存在幽门螺杆菌感染。幽门螺杆菌耐药性最常见的是克拉霉素(n=19;38%),其次是甲硝唑(n=15;30%),最不常见的是阿莫西林(n=13;26%)。14 名儿童(28%)存在 1 种抗生素耐药。3 名儿童(6%)存在双重耐药,9 名儿童(18%)存在三重耐药。在整个研究组中,24 名儿童(48%)对所有 3 种抗生素均敏感。
在波兰东北部首次对未经治疗的儿童进行的这项研究中,我们发现存在至少 1 种抗生素耐药的幽门螺杆菌菌株比例较高。我们的结果可能有助于在本地区选择合适的抗生素治疗幽门螺杆菌。